MarketSpotlight Open app

Biggest moves on record

Every trading day we hold, as a bar. The five biggest are marked.

  1. 1+5.8%11 Feb 2026Moderate
  2. 2+5.2%7 Jul 2026Moderate
  3. 3+4.2%17 Oct 2025Moderate
  4. 4+4.2%2 Jul 2026Low
  5. 5+4.0%21 Jan 2026Moderate

Every day, by size of move

252 trading days, 2025–2026. One square is one day.

  • Max10.4%
  • Very High10.4%
  • High20.8%
  • Moderate135.2%
  • Low9236.5%
  • Very Low14356.7%

Coming up

Dates that often move Gilead Sciences, over the next 30 days. Days are in UTC, the world's standard clock.

  • Thu 29 Octin 9 days Gilead Sciences resultsThe company reports its profits after the market closes.

How it reacted to its last results

ReportedResultOn the day
4 Aug 2026 Beat−$6.75 vs −$7.25 expected −2.6%
7 May 2026 Beat$2.03 vs $1.91 expected −2.0%
10 Feb 2026 Beat$1.86 vs $1.81 expected +5.8%
30 Oct 2025 Beat$2.47 vs $2.14 expected +1.1%

Beat or missed means profit per share came in above or below what experts expected. The price move is for the first trading day the results could move.

Compared with its neighbours

On a normal day, GILD moves about 1.1% up or down. That is about average for the shares we follow.

In the news

Recent headlines about Gilead Sciences, from the outlets that wrote them.

  1. 01ad-hoc-news.de1 hour agoGilead Sciences stock: BofA raised target for Gilead Sciences stock to USD 164.00
  2. 02Investing.com6 hours agoBofA raises Gilead Sciences stock price target on positive trial data
  3. 03ad-hoc-news.de6 hours agoGilead reports trial success. Gilead Sciences stock is valued at USD 189.8 billion gradually
  4. 04MarketBeat8 hours ago15,240 Gilead Sciences, Inc. $GILD Shares Bought by CWA Asset Management Group LLC
  5. 05ad-hoc-news.de10 hours agoGilead Sciences stock pill meets trial goal, slightly lower pre-market
  6. 06Yahoo Finance11 hours agoHow Investors Are Reacting To Gilead Sciences (GILD) FDA Drug Approvals